Objectives: Despite the increased popularity of US, there remains a lack of formal standard references, especially for procedures involving the face. Moreover, while there is a considerable amount of information available in the literatures related to US, there is very little information related to US imaging of the face. Recently, the importance on the facial anatomy has been reconsidered as the interest on the facial aesthetics is increasing. In this reason, it is speculated that the utilization of the facial US will be soon broadened to prevent the side effects.

Introduction: The BoNT-A and filler injection are widely-applied techniques for managing masseteric hypertrophy, gummy smiling, several facial wrinkles, volume augmentation, and facial asymmetry that includes the asymmetrical smile. However, inaccurate injections sometimes may result in mild side effects such as bleeding, bruising, or muscle bulging, along with more serious side effects including skin necrosis and blindness. For these reasons, it is crucial to understand regional topography of the skin, facial superficial fat and underlying fascia structures when performing minimally invasive procedures.

Results: Despites wide ranges of cadaveric studies to prevent the side effects, the US-guided injection technique could be the first choice of procedure than other blind techniques. I believe that the procedures under US leads to more accurate injections into the targeted area with less complications.

Conclusion: Through my talks, I would like to introduce the update US anatomical findings of the face and provide the reference images on each landmark of the face. Therefore, an in-depth morphological study using an US imaging system can yield depth and orientation on the facial muscles, blood vessels, and fascial structures of the facial area that were previously impossible to obtain. This provides crucial anatomical knowledge that can be utilized in various clinical applications such as the US-guided injections with safety and effectiveness.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The frontalis and corrugator supercilii muscle is situated across the forehead and is a representative target muscle for botulinum neurotoxin injections aimed at treating horizontal wrinkles in this region.

However, a lack of anatomical information regarding the shape and thickness of the frontalis may lead to unexpected adverse effects, such as ptosis and samurai eyebrows, due to the lack of detail on anatomical variation. Achieving the maximum effect using the minimal amount of botulinum neurotoxin requires a precise injection into the frontalis muscle.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: improving the technique for lip injections

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Complications of facial cosmetic botulinum toxin A injection:

An update literature review and a parallel from cases sent to IMCAS ALERT - INJECTABLES (8 years].

Introduction: Cosmetic procedures have increased manifolds all over the world. Injectable treatments like botulinum toxin are becoming more popular owing to their rapid, well- defined, and lasting results for the reduction of facial fine lines, wrinkles, and facial rejuvenation. These treatments are quite safe but can have certain minor adverse effects.

Materials / method: We analyze adverse events of facial cosmetic BoNT-A injections reported in the recent literature. A systematic search of MEDLINE and EMBASE was performed for studies reporting complications after cosmetic BoNT- A to assess complication rate.
IMCAS ACADEMY being the most important e-learning platform on this subject, we draw a parallel with these data of literature and such cases received for guidance from IMCAS ALERT INJECTABLES in its 8 years of existence/activity.

Conclusion: Botulinum toxin is a powerful medication that has been used to treat various conditions in recent years. Knowing the anatomic landmarks, muscle function, identifying baseline asymmetry, accounting for potential migration of the toxin, and site-specific precautions can mitigate the incidence of unwanted adverse reactions. Cosmetic BoNT-A injections can be considered safe, and most complications are mild and transient.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Recent publications that are redefining and advancing neuromodulator injection paradigms will be presented during this session. At the end of this presentation, participants will have the tools to optimize their cosmetic botulinum toxin treatment results.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Allergan Aesthetics, Evolus, Medytox, Galderma, Revance

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability